Article thumbnail
Location of Repository

Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors

By Catherine L Olsen, Pin-Pin Hsu, Jens Glienke, Gabor M Rubanyi and Alan R Brooks


BACKGROUND: The Hedgehog (Hh) signaling pathway regulates a variety of developmental processes, including vasculogenesis, and can also induce the expression of pro-angiogenic factors in fibroblasts postnatally. Misregulation of the Hh pathway has been implicated in a variety of different types of cancer, including pancreatic and small-cell lung cancer. Recently a putative antagonist of the pathway, Hedgehog-interacting protein (HIP), was identified as a Hh binding protein that is also a target of Hh signaling. We sought to clarify possible roles for HIP in angiogenesis and cancer. METHODS: Inhibition of Hh signaling by HIP was assayed by measuring the induction of Ptc-1 mRNA in TM3 cells treated with conditioned medium containing Sonic hedgehog (Shh). Angiogenesis was assayed in vitro by EC tube formation on Matrigel. Expression of HIP mRNA was assayed in cells and tissues by Q-RT-PCR and Western blot. HIP expression in human tumors or mouse xenograft tumors compared to normal tissues was assayed by Q-RT-PCR or hybridization of RNA probes to a cancer profiling array. RESULTS: We show that Hedgehog-interacting protein (HIP) is abundantly expressed in vascular endothelial cells (EC) but at low or undetectable levels in other cell types. Expression of HIP in mouse epithelial cells attenuated their response to Shh, demonstrating that HIP can antagonize Hh signaling when expressed in the responding cell, and supporting the hypothesis that HIP blocks Hh signaling in EC. HIP expression was significantly reduced in tissues undergoing angiogenesis, including PC3 human prostate cancer and A549 human lung cancer xenograft tumors, as well as in EC undergoing tube formation on Matrigel. HIP expression was also decreased in several human tumors of the liver, lung, stomach, colon and rectum when compared to the corresponding normal tissue. CONCLUSION: These results suggest that reduced expression of HIP, a naturally occurring Hh pathway antagonist, in tumor neo-vasculature may contribute to increased Hh signaling within the tumor and possibly promote angiogenesis

Topics: Research Article
Publisher: BioMed Central
Year: 2004
DOI identifier: 10.1186/1471-2407-4-43
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2001). AchillesGerte E, McDonnell TJ, D'Amato RJ: Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. J Natl Cancer I
  2. (2003). Angiogenesis and apoptosis. Semin Cancer Biol
  3. (2003). Baylin SB: Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature
  4. (2001). De Sauvage FJ, Epstein EH: Activation of expression of hedgehog target genes in basal cell carcinomas.
  5. (2001). DM: A freely diffusible form of Sonic hedgehog mediates longrange signalling. Nature
  6. (2003). Epstein EH: Evidence for lack of enhanced hedgehog target gene expression in common extracutaneous tumors. Cancer Res
  7. (2002). Gli and Hedgehog in cancer: tumours, embryos and stem cells. Nature Reviews
  8. (2002). Grabel L: Hedgehog is required for murine yolk sac angiogenesis. Development
  9. (2002). Growth inhibitionof prostate cancer xenografts by halofuginone. The Prostate
  10. (2003). Hebrok M: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature
  11. (2002). Hennequin LF: ZD6474 Inhibits Vascular Endothelial Growth Factor Signaling, Angiogenesis, and Tumor Growth following Oral Administration. Cancer Res
  12. (2001). Isner JM: The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nature Med
  13. (2002). Kaneko F: Expression of a sonic hedgehog signal transducer, hedgehog-interacting protein, by human basal cell carcinoma.
  14. (2003). Losordo DW: Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia. Circulation
  15. (1999). McMahon AP: Vertebrate hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature
  16. (2001). MH: Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development
  17. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell
  18. (2002). Perrimon N: Hedgehog signal transduction: recent findings. Curr Opin Genet Dev
  19. (2001). Rafii S: Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med
  20. (2000). RK: Angiogenesis in cancer and other diseases. Nature
  21. (1997). Ruiz i Altaba A: Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature
  22. (2001). Ruiz i Altaba A: The sonic hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development
  23. (1992). Shing Y: Angiogenesis.
  24. (1999). SJ: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science
  25. (1993). T: Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res
  26. (1996). Tabin CJ: Regulation of Patched by Sonic hedgehog in the developing neural tube.
  27. (2003). The therapeutic potential of novel antiangiogenic therapies. Expert Opin Inv Drugs
  28. (2000). Transducing the hedgehog signal. Cell
  29. (2000). Vascular-specific growth factors and blood vessel formation. Nature
  30. (1987). Vogelstein B: Identification of an amplified, highly expressed gene in a human glioma. Science
  31. (2003). Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.